455 related articles for article (PubMed ID: 16980809)
1. Fabry disease: guidelines for the evaluation and management of multi-organ system involvement.
Eng CM; Germain DP; Banikazemi M; Warnock DG; Wanner C; Hopkin RJ; Bultas J; Lee P; Sims K; Brodie SE; Pastores GM; Strotmann JM; Wilcox WR
Genet Med; 2006 Sep; 8(9):539-48. PubMed ID: 16980809
[TBL] [Abstract][Full Text] [Related]
2. Gastroenterological complications of Anderson-Fabry disease.
Buda P; Książyk J; Tylki-Szymanska A
Curr Pharm Des; 2013; 19(33):6009-13. PubMed ID: 23448457
[TBL] [Abstract][Full Text] [Related]
3. Fabry disease: focus on cardiac manifestations and molecular mechanisms.
Perrot A; Osterziel KJ; Beck M; Dietz R; Kampmann C
Herz; 2002 Nov; 27(7):699-702. PubMed ID: 12439642
[TBL] [Abstract][Full Text] [Related]
4. Fabry nephropathy: a review - how can we optimize the management of Fabry nephropathy?
Waldek S; Feriozzi S
BMC Nephrol; 2014 May; 15():72. PubMed ID: 24886109
[TBL] [Abstract][Full Text] [Related]
5. Enzyme replacement therapy stabilizes obstructive pulmonary Fabry disease associated with respiratory globotriaosylceramide storage.
Wang RY; Abe JT; Cohen AH; Wilcox WR
J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S369-74. PubMed ID: 18937048
[TBL] [Abstract][Full Text] [Related]
6. Fabry disease.
Germain DP
Orphanet J Rare Dis; 2010 Nov; 5():30. PubMed ID: 21092187
[TBL] [Abstract][Full Text] [Related]
7. [Fabry disease. An interdisciplinary challenge].
Cybulla M; Neumann HP
Dtsch Med Wochenschr; 2007 Oct; 132(43):2271-7. PubMed ID: 17940933
[TBL] [Abstract][Full Text] [Related]
8. [Neurological complications of Fabry-disease].
Vastagh I; Constantin T; Kéri A; Rudas G; Fekete G; Bereczki D
Ideggyogy Sz; 2011 Jan; 64(1-2):29-35. PubMed ID: 21428036
[TBL] [Abstract][Full Text] [Related]
9. Anderson-Fabry disease: a multiorgan disease.
Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
[TBL] [Abstract][Full Text] [Related]
10. Renal complications of Fabry disease.
Basic-Jukic N; Kes P; Coric M; Basic-Kes V
Curr Pharm Des; 2013; 19(33):6046-50. PubMed ID: 23448456
[TBL] [Abstract][Full Text] [Related]
11. [Fabry disease in cardiology: Diagnosis and therapeutic approaches].
Çavuşoğlu Y; Özpelit E; Arslan N; Demir M; Kahveci G; Onay H; Ökçün EÖB; Tufekcioglu O; Tülüce SY; Yıldırım GK
Turk Kardiyol Dern Ars; 2020 Dec; 48(Suppl 2):1-42. PubMed ID: 33476309
[TBL] [Abstract][Full Text] [Related]
12. Department-related tasks and organ-targeted therapy in Fabry disease: an interdisciplinary challenge.
Weidemann F; Sommer C; Duning T; Lanzl I; Möhrenschlager M; Naleschinski D; Arning K; Baron R; Niemann M; Breunig F; Schaefer R; Strotmann J; Wanner C
Am J Med; 2010 Jul; 123(7):658.e1-658.e10. PubMed ID: 20609689
[TBL] [Abstract][Full Text] [Related]
13. The expanding clinical spectrum of Anderson-Fabry disease: a challenge to diagnosis in the novel era of enzyme replacement therapy.
Hauser AC; Lorenz M; Sunder-Plassmann G
J Intern Med; 2004 Jun; 255(6):629-36. PubMed ID: 15147526
[TBL] [Abstract][Full Text] [Related]
14. Stroke and Chronic Kidney Disease in Fabry Disease.
Tapia D; Kimonis V
J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105423. PubMed ID: 33160817
[TBL] [Abstract][Full Text] [Related]
15. [Fabry disease: proposed guidelines from a French expert group for its diagnosis, treatment and follow-up].
Lidove O; Bekri S; Goizet C; Khau Van Kien A; Aractingi S; Knebelmann B; Choukroun G; Tsimaratos M; Redonnet-Vernhet I; Lacombe D; Jaussaud R
Presse Med; 2007; 36(7-8):1084-97. PubMed ID: 17276649
[TBL] [Abstract][Full Text] [Related]
16. Enzyme replacement therapy for Fabry disease, an inherited nephropathy.
Desnick RJ; Banikazemi M; Wasserstein M
Clin Nephrol; 2002 Jan; 57(1):1-8. PubMed ID: 11837797
[TBL] [Abstract][Full Text] [Related]
17. Genetics and Gene Therapy of Anderson-Fabry Disease.
Simonetta I; Tuttolomondo A; Di Chiara T; Miceli S; Vogiatzis D; Corpora F; Pinto A
Curr Gene Ther; 2018; 18(2):96-106. PubMed ID: 29618309
[TBL] [Abstract][Full Text] [Related]
18. A diagnosis of Fabry gastrointestinal disease by chance: a case report.
Feriozzi S; Torre ES; Ranalli TV; Cardello P; Morrone A; Ancarani E
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):163-5. PubMed ID: 17273003
[TBL] [Abstract][Full Text] [Related]
19. Clinical course and pathological findings of two late-onset Fabry hemizygous patients including mulberry cell counts after enzyme replacement therapy.
Shimohata H; Yamashita M; Ohgi K; Maruyama H; Takayasu M; Hirayama K; Kobayashi M
CEN Case Rep; 2020 Aug; 9(3):237-242. PubMed ID: 32189245
[TBL] [Abstract][Full Text] [Related]
20. Fabry disease: A fundamental genetic modifier of cardiac function.
Tadevosyan A
Curr Res Transl Med; 2017; 65(1):10-14. PubMed ID: 28340691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
